Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/107921
Citations
Scopus Web of ScienceĀ® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRachul, C.-
dc.contributor.authorToews, M.-
dc.contributor.authorCaulfield, T.-
dc.date.issued2016-
dc.identifier.citationJournal of Cystic Fibrosis, 2016; 15(5):624-629-
dc.identifier.issn1569-1993-
dc.identifier.issn1873-5010-
dc.identifier.urihttp://hdl.handle.net/2440/107921-
dc.description.abstractAbstract not available-
dc.language.isoen-
dc.publisherElsevier-
dc.rightsChristen Rachul, Maeghan Toews, Timothy Caulfield-
dc.source.urihttp://dx.doi.org/10.1016/j.jcf.2016.03.006-
dc.subjectKalydeco; orphan drug; Venture philanthropy; drug reimbursement; patient access-
dc.titleControversies with Kalydeco: newspaper coverage in Canada and the United States of the cystic fibrosis "Wonder Drug"-
dc.typeJournal article-
dc.identifier.doi10.1016/j.jcf.2016.03.006-
pubs.publication-statusPublished-
dc.identifier.orcidToews, M. [0000-0002-9027-7411]-
Appears in Collections:Aurora harvest 8
Law publications

Files in This Item:
File Description SizeFormat 
RA_hdl_107921.pdf
  Restricted Access
Restricted Access308.43 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.